
    
      The Protégé Study - A Multinational Clinical Trial of MGA031 for Preserving the Capability to
      Produce Insulin, Reducing Insulin Usage and Improving Blood Sugar Levels in Children and
      Adults With Recent-Onset Type 1 Diabetes Mellitus
    
  